Skip to main content

News

By Jeff Lagasse | 04:35 pm | January 27, 2022
The investments will be aided by a strong financial showing in 2021, with total operating revenue hitting $12.4 billion.
By Jeff Lagasse | 12:41 pm | January 27, 2022
Bamlanivimab and etesevimab, which are administered in tandem, and REGEN-COV are not effective against Omicron, the FDA said.
By Susan Morse | 11:40 am | January 27, 2022
The Nashville-based health system has invested approximately $6.6 billion over the last five years, including other expansions currently in progress.
By Susan Morse | 06:58 pm | January 26, 2022
This is the first performance improvement plan issued by the Massachusetts Health Policy Commission.
By Jeff Lagasse | 04:11 pm | January 26, 2022
AGS believes it's premature for CMS to issue a coverage determination for other antibodies in the pipeline that don't yet have FDA approval.
By Susan Morse | 11:49 am | January 26, 2022
The AHA is also urging the Federal Trade Commission to investigate reports of anticompetitive pricing by nurse-staffing agencies. 
By Jeff Lagasse | 11:07 am | January 26, 2022
The agency is not, however, withdrawing the emergency temporary standard as a proposed rule, saying it will work on a permanent standard.
By Jeff Lagasse | 04:12 pm | January 25, 2022
The senators framed the widespread availability of free tests - along with vaccination - as a means of eventually ending the pandemic.
By Jeff Lagasse | 12:38 pm | January 25, 2022
Uncertainty over when the waiver will end may create barriers to entry for new participants, the groups say.
By Susan Morse | 10:50 am | January 25, 2022
Independent physician groups, which include telehealth docs, must now accept a rate that someone else has negotiated, expert says.